10-Q: U.S. Physical Therapy Reports Mixed Q3 Results Amid Clinic Closures

U.S. Physical Therapy, Inc. announced its third-quarter results, showing a decrease in net income attributable to USPH shareholders, impacted by clinic closures, while also reporting growth in revenue and adjusted EBITDA.

Summary

• U.S. Physical Therapy, Inc. reported a net income attributable to USPH shareholders of $6.6 million for the third quarter of 2024, a decrease from $9.3 million in the same period of 2023.
• The company's earnings per share for the quarter were $0.39, down from $0.51 in the prior year.
• These results were impacted by $2.5 million in charges related to the closure of 32 clinics during the quarter.
• Excluding these closure costs, net income would have been $9.1 million, with earnings per share of $0.55.
• Net revenue for the quarter increased by 12% to $168 million, up from $150 million in the third quarter of 2023.
• The company's adjusted EBITDA for the quarter was $21.1 million, an increase from $18.6 million in the prior year.
• For the nine months ended September 30, 2024, net income attributable to USPH shareholders was $22.2 million, compared to $27.6 million for the same period in 2023.
• Earnings per share for the nine-month period were $1.32, down from $1.72 in the prior year.
• The nine-month results included a $2.9 million charge related to the closure of 43 clinics.
• Excluding these closure costs, net income would have been $25.1 million, with earnings per share of $1.52.
• The company's net revenue for the nine-month period was $490.9 million, up from $450 million in the prior year.
• The company's adjusted EBITDA for the nine-month period was $60 million, up from $58.9 million in the prior year.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with positive revenue growth and adjusted EBITDA, but negative impacts from clinic closures and decreased net income. The sentiment is neutral to slightly negative due to the mixed results and the challenges the company faces.

Positives

• Net revenue increased by 12% in the third quarter of 2024 compared to the same period in 2023.
• Adjusted EBITDA increased to $21.1 million in the third quarter of 2024, up from $18.6 million in the third quarter of 2023.
• Net rate per patient visit increased by 3.2% to $105.65 in the third quarter of 2024.
• Total patient visits increased by 6% to 1,317,051 in the third quarter of 2024.
• The company's interest rate swap arrangement generated $2.8 million in interest savings for the nine months ended September 30, 2024.
• The company has $175 million in available credit under its revolving facility as of September 30, 2024.

Negatives

• Net income attributable to USPH shareholders decreased to $6.6 million in the third quarter of 2024, down from $9.3 million in the third quarter of 2023.
• Earnings per share decreased to $0.39 in the third quarter of 2024, down from $0.51 in the third quarter of 2023.
• The company incurred $2.5 million in charges related to the closure of 32 clinics during the third quarter of 2024.
• Gross profit margin from physical therapy operations decreased to 16.5% in the third quarter of 2024 from 18.0% in the third quarter of 2023.
• Operating income decreased to $14.7 million in the third quarter of 2024 from $15.9 million in the third quarter of 2023.

Risks

• The company's financial performance is subject to changes in Medicare rules and guidelines, which could impact reimbursement rates.
• The company faces risks related to compliance with federal and state laws regarding patient information privacy.
• Competitive, economic, and reimbursement conditions in the market could lead to clinic closures and impairment charges.
• The company's debt and financial obligations could adversely affect its financial condition and ability to operate.
• The company's business depends on hiring, training, and retaining qualified employees, including physical therapists.
• The company faces a competitive environment in the IIP business, which could result in the termination or non-renewal of contracts.
• The company's ability to identify and complete acquisitions and integrate acquired businesses is a risk.
• The company is subject to risks related to maintaining its information technology systems and protecting against cyber-attacks.
• The company is subject to risks related to enforcing non-competition covenants with employed therapists.
• The company is subject to risks related to maintaining necessary insurance coverage.

Future Outlook

The company plans to continue acquiring outpatient physical therapy practices, developing satellite clinics, and acquiring companies in the IIP sector. The company believes its cash and credit facilities are sufficient to fund operations through at least September 30, 2025.

Management Comments

• Management believes providing Adjusted EBITDA and Operating Results to investors is useful information for comparing our period-to-period results as well as for comparing with other similar businesses since most do not have redeemable instruments and therefore have different equity structures.
• Management uses Adjusted EBITDA, Operating Results, and other non-GAAP measures, which eliminate certain items described above that can be subject to volatility and unusual costs, as the principal measures to evaluate and monitor financial performance period over period.

Industry Context

The company operates in the outpatient physical therapy and industrial injury prevention services sectors, which are subject to regulatory changes, reimbursement pressures, and competition. The company's performance is influenced by factors such as Medicare reimbursement rates, patient volumes, and the ability to manage costs effectively. The acquisition of MSO Metro, LLC is a strategic move to expand its management services and reach.

Comparison to Industry Standards

• The company's revenue growth of 12% in the third quarter is solid compared to the broader healthcare services industry, which has seen moderate growth.
• The company's adjusted EBITDA margin of 12.6% in the third quarter is within the range of other publicly traded physical therapy companies, such as ATI Physical Therapy and Select Medical, although these companies have different business models and may not be directly comparable.
• The company's clinic closure costs are a significant factor impacting profitability, which is not typical for all companies in the sector, but is a common strategy for companies optimizing their clinic footprint.
• The company's net rate per patient visit of $105.65 is competitive within the industry, reflecting its ability to negotiate favorable reimbursement rates.
• The company's focus on acquisitions is a common strategy in the fragmented physical therapy market, but the success of these acquisitions depends on effective integration and management.

Legal Proceedings

• The company is a party to various legal actions, proceedings, and claims in the ordinary course of business.
• The company is subject to regulatory and other governmental audits and investigations.
• The company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and earnings per share, but encouraged by the revenue growth and adjusted EBITDA.
• Employees may be affected by clinic closures and changes in staffing.
• Customers may experience changes in clinic locations and service availability.
• Suppliers may be impacted by changes in the company's operations and acquisitions.
• Creditors may be concerned about the company's debt and financial obligations.

Next Steps

• The company will continue to focus on acquiring outpatient physical therapy practices and companies in the IIP sector.
• The company will continue to develop satellite clinics in existing partnerships.
• The company will continue to monitor and manage its debt and financial obligations.
• The company will continue to evaluate and optimize its clinic footprint.

Key Dates

Keywords

physical therapy, industrial injury prevention, healthcare, rehabilitation, clinic acquisitions, Medicare reimbursement, EBITDA, net revenue, patient visits, clinic closures